When would you recommend cefuroxime for an active runner with a history of antibiotic‑associated diarrhea (possible Clostridioides difficile infection), who is reluctant to use fluoroquinolones and currently has loose stools?

I would not recommend cefuroxime for this patient—it's one of the worst choices given their history of antibiotic-associated diarrhea.

Cefuroxime carries one of the highest risks for triggering Clostridioides difficile infection (CDI), with an adjusted odds ratio of 4.57 compared to safer antibiotics like doxycycline 1. For a patient with prior antibiotic-associated diarrhea (even if C. diff was unconfirmed), exposing them to cefuroxime would be clinically reckless.

Why Cefuroxime is Particularly Problematic Here

The evidence is unambiguous: second-generation cephalosporins like cefuroxime are among the antibiotics most strongly associated with CDI 1. In a large retrospective cohort of over 36 million patients, cefuroxime ranked as the third-highest risk antibiotic for community-acquired CDI, behind only clindamycin and cefdinir 1.

The Risk Profile

• Multiple-dose cephalosporin regimens dramatically increase C. diff risk 2
• Cephalosporins (particularly third-generation, but second-generation are also implicated) are consistently identified as high-risk agents for CDI 3, 4
• The FDA label explicitly warns about Clostridioides difficile-associated diarrhea (CDAD) with cefuroxime, noting it can occur up to 2 months after administration 4

Your Patient's Current Situation

This patient is already developing loose stools—a red flag that should make you immediately reconsider any antibiotic, especially a high-risk one. They're also:

• An active runner (quality of life matters—CDI would devastate their activity level)
• Reluctant to use fluoroquinolones (reasonable given their own risks)
• Already at elevated baseline risk due to prior antibiotic-associated diarrhea

When Cefuroxime Might Be Acceptable (Rare Scenarios)

The only clinical contexts where cefuroxime appears in guidelines are:

1. Complicated intra-abdominal infections (community-acquired, mild-to-moderate) when combined with metronidazole for anaerobic coverage 5, 6
2. Surgical prophylaxis in very specific circumstances—and even then, a single-dose regimen with gentamicin is superior to multiple cefuroxime doses for preventing C. diff 2

Neither of these scenarios applies to your patient based on the limited information provided.

What You Should Consider Instead

Without knowing the specific infection you're treating, here's the algorithmic approach:

For Respiratory Infections:

• Amoxicillin (if bacterial pneumonia suspected)
• Doxycycline (lowest CDI risk among commonly used antibiotics) 1
• Azithromycin (if atypical coverage needed)

For Urinary Tract Infections:

• Nitrofurantoin (though be aware it does carry some CDI risk in older patients with risk factors) 1
• Fosfomycin (single-dose, minimal gut disruption)

For Skin/Soft Tissue:

• Cephalexin (first-generation cephalosporin, lower CDI risk than cefuroxime)
• Dicloxacillin (if MSSA suspected)

If Fluoroquinolones Are Truly Necessary:

Despite the patient's reluctance, if the clinical scenario demands broad gram-negative coverage and no alternatives exist, a short course of a fluoroquinolone may still be safer than cefuroxime for this specific patient. Fluoroquinolones carry a 4.05 adjusted OR for CDI 1—still high, but lower than cefuroxime's 4.57.

Critical Pitfalls to Avoid

1. Don't dismiss the "loose stools" as unrelated—this could be early antibiotic-associated diarrhea or even recurrent C. diff
2. Don't use multiple-dose cephalosporin regimens when single-dose or alternative agents are available 2
3. Don't assume prior "unconfirmed" C. diff means it wasn't C. diff—many cases go undiagnosed, and this patient's gut microbiome may already be compromised

Bottom Line

There is essentially no clinical scenario where cefuroxime would be your best choice for this patient. The combination of prior antibiotic-associated diarrhea, current loose stools, and cefuroxime's high CDI risk creates an unacceptable probability of triggering severe, potentially recurrent C. difficile infection that could sideline this active runner for months and require treatments ranging from oral vancomycin to fecal microbiota transplantation 3, 7.

Choose a narrower-spectrum agent based on the specific infection, prioritize antibiotics with lower gut microbiome disruption, and if you must use a broader agent, avoid second- and third-generation cephalosporins in this patient population.